(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Which European palace do you fantasy about visiting? Vote! - 2A definitive Frozen yogurt Standoff: Which Flavor Rules?
- 3Heat Wave Fuels Massive Wildfire In Australia
- 4Instructions to Utilize Your Brain science Certification to Work on Corporate Culture
- 5Turkey’s intel chief lays out country’s vision for Middle East, world
- Investigating Inside Plan and Home Style: Change Your Residing Space
- Why are NASA's Artemis astronauts wearing orange? What are they bringing to space? What to know about the preparation for their moon mission.
- Top Music and Dance Celebration: Which One Gets You Going?
- Taste the World: Five Food sources That Have Dazzled Worldwide Palates
- We analyzed Philly street scenes and identified signs of gentrification using machine learning trained on longtime residents’ observations
- Israel’s mixed messaging on Christmas draws controversy
- Figure out What Shift Differentials Mean for Your General Attendant Compensation
- Russia Establishing Long-Range Drone Bases In Belarus, Warns Ukraine
- Israel strikes south Lebanon after first direct talks in decades
